Enrique Grande-Pulido - Publications

Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors.

Journal: Frontiers in oncology

Published: January 12, 2026

Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors.

Journal: Frontiers in endocrinology

Published: March 06, 2021

Novel concepts for initiating multitargeted kinase inhibitors in radioactive iodine refractory differentiated thyroid cancer.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: September 16, 2017

Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 26, 2015

Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors.

Journal: The oncologist

Published: November 02, 2015

Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach?

Journal: Clinical genitourinary cancer

Published: February 14, 2015

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 22, 2015

Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.

Journal: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

Published: November 05, 2014

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.

Journal: BMC cancer

Published: May 04, 2014

A comprehensive review of poorly differentiated neuroendocrine carcinomas (pdNECs): a niche to find novel opportunities.

Journal: Current pharmaceutical design

Published: March 14, 2014

Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.

Journal: BMC cancer

Published: December 04, 2013

Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies.

Journal: Advances in therapy

Published: September 24, 2013